LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q1 25 Rev. Estimate To 10.3 M From 11.3 M 8/13/2024 5:00:52 PM
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) FY24 Rev. Estimate To 60.0 M From 65.3 M 8/13/2024 5:00:42 PM
  • Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q4 24 Rev. Estimate To 19.6 M From 21.4 M 8/13/2024 5:00:32 PM
  • Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q3 24 Rev. Estimate To 7.8 M From 9.9 M 8/13/2024 5:00:21 PM
  • Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) FY25 Estimate To 0.06 From 0.42 8/13/2024 4:59:58 PM
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) Q4 25 Estimate To 0.05 From 0.13 8/13/2024 4:59:47 PM
  • Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q3 25 Estimate To 0.04 From 0.12 8/13/2024 4:59:34 PM
  • Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q2 25 Estimate To 0.00 From 0.09 8/13/2024 4:59:25 PM
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) Q1 25 Estimate To -0.02 From 0.08 8/13/2024 4:59:16 PM
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) FY24 Estimate To 0.44 From 0.84 8/13/2024 4:59:04 PM
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) Q4 24 Estimate To 0.28 From 0.42 8/13/2024 4:58:53 PM
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) Q3 24 Estimate To -0.12 From 0.02 8/13/2024 4:58:41 PM
  • Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $14 Down From $16 Price Target 8/13/2024 4:58:16 PM
  • Fennec Pharma Q2 Net Loss $5.6 Mln Or $0.20/Shr Vs Loss Of $5.4 Mln Or $0.21/Shr Last Year 8/13/2024 6:18:59 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap